All
Pulsed terbinafine may be best option for some with toenail onychomycosis
May 1st 2004Washington - The therapy of choice for the treatment of toenail onychomycosis remains continuous doses of terbinafine (Lamisil), according to Erin Warshaw, M.D. In certain situations, however, pulse dosing may play a role.
Integrated analysis underlines etanercept efficacy in psoriasis
May 1st 2004Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.
Contact dermatitis from topicalstops list of adverse drug reactions
May 1st 2004Boca Raton, Fla. - Contact dermatitis from topical medications is the most common type of adverse drug reaction, and allergic contact dermatitis is the most common and most important form of contact dermatitis induced by topical drugs, according to James S. Taylor, M.D., head of the industrial dermatology section of the department of dermatology at the Cleveland Clinic Foundation in Cleveland. "Patients with medicament contact dermatitis usually have a good prognosis, but with a propensity for relapse," he said.
Pimecrolimus cream shows better tolerability
May 1st 2004Washington - Pimecrolimus cream 1 percent showed better local tolerability than tacrolimus ointment 0.03 percent in pediatric patients with moderate atopic dermatitis, and the patients or their primary caregivers rated most of the formulation attributes of the pimecrolimus cream as being significantly better than those of the tacrolimus ointment, according to a recent Phase IV study presented at the American Academy of Dermatology annual meeting.
Oral tazarotene for psoriasis: Effective on difficult-to-treat area
May 1st 2004Washington - Oral tazarotene offers rapid and durable clinical improvement in difficult-to-treat psoriatic lesions on the elbows and knees, said Sewon Kang, M.D., at the 62nd annual meeting of the American Academy of Dermatology.
Pediatric MRSA skin abscessesmight not require antibiotics to heal
May 1st 2004Dallas - Most community-acquired methicillin-resistant staphylococcus aureus (MRSA) skin and soft tissue abscesses smaller than 5 cm can be managed with standard incision and drainage, without the need for antibiotic therapy, according to a new study.
Being charitable is considered fraudulent?
May 1st 2004Dr. Bob has a large, mostly medical, dermatology practice. The practice is divided almost equally into patients whose health care insurance is provided by managed care organizations and those whose insurance is provided by federally insured policies with either Medicare or Medicaid.
Medical errors reduced using electronic means
May 1st 2004Seattle - Reducing medical errors can be greatly facilitated by bringing state-of-the-art information technology into offices, clinics, pharmacies, and hospitals, according to Paul Tang, M.D. "The status quo is unacceptable," he said. "We can't manage the amount of paper we have now as healthcare professionals."
Derms tackle patients' quality-of-life issues with need for rosacea-specific instrument
May 1st 2004Washington - Investigators developing a rosacea-specific quality-of-life instrument (RosaQoL) have demonstrated its reliability and validity and have begun testing its responsiveness to changes in rosacea severity, said Suephy C. Chen, M.D., M.S., at the annual meeting of the American Academy of Dermatology.
Aggressive treatment wins battle of juvenile dermatomyositis
May 1st 2004Washington - Timely diagnosis of juvenile dermatomyositis is critical because early aggressive management with immunosuppressive agents, even for patients with amyopathic disease, is the best method for preventing calcinosis that is a source of significant morbidity for these children, said Amy S. Paller, M.D., at the annual meeting of the American Academy of Dermatology.
Hair loss in elderly may pack a potent psychological punch; evaluate carefully
May 1st 2004Washington - While hair loss may become more acceptable with increasing age, for some older people it is psychologically devastating and adds to the string of losses they may encounter, said Janet L. Roberts, M.D., at the annual meeting of the American Academy of Dermatology.
Botox has long duration of action for Tx of axillary hyperhidrosis
May 1st 2004Washington - Intradermal botulinum toxin type A (Botox) for the treatment of primary axillary hyperhidrosis produces a durable effect, with nearly half of patients requiring only one treatment over a one-year period, according to study data released at the annual meeting of the American Academy of Dermatology here.
Not all topical anesthetics are alike
May 1st 2004Waikoloa, Hawaii - The increase in the number of topical anesthesia options available mandates that dermatologists consider how they compare with respect to efficacy, safety, and patient convenience when selecting an agent to minimize the pain of a cutaneous procedure, said Dina N. Anderson, M.D., at the recent annual Hawaii Dermatology Seminar.
Antimicrobial dressingsretooled for the present
May 1st 2004Washington - The phrase "what is old is new again" aptly describes the current status of antimicrobial dressings, which, thanks to a new generation of products, are making a comeback in the woundcare arena, said Marketa Limova, M.D., at the annual meeting of the American Academy of Dermatology.